MindMaze Secures Investments Of $105 Million To Consolidate Development Of Digital Therapeutic Solutions For Neurological Diseases

MindMaze, which provides tech-enabled protocolized software and hardware peripherals to address serious cognitive and movement deficits, secured a $105 million financing to accelerate its global commercial growth plans. It plans to consolidate its clinical development pipeline of digital therapeutic solutions for a wide spectrum of neurological diseases.

The financing was led by Concord Health Partners (Concord), a U.S.-based health care private equity firm focused on investing in and supporting healthcare companies with innovative technologies and solutions that address quality, cost, and access to care, along with other investors. Existing investor AlbaCore Capital Group also participated in the . . .